Pfizer’s Anthony Coyle and PhRMA’s John J. Castellani Headline New York Biotechnology Association Conference, April 6-7
NEW YORK--(BUSINESS WIRE)-- New York Biotechnology Association (NYBA), the voice of New York State’s biotechnology industry, today announced the keynote lineup for the Association’s 20th Annual Meeting, April 6-7, at the Marriott Marquis Hotel in New York City. The theme of the conference is “The Cures Start Here Because the Science Starts Here,” and the event will feature a robust program celebrating New York’s contributions to the global biopharmaceutical industry.
The luncheon keynote speaker for Wednesday, April 6, will be Anthony Coyle, PhD, Head of Pfizer’s newly-announced New York Center for Therapeutic Innovation, a network of partnerships that aims to speed the translation of biomedical research into life-saving medicines. Seven major research-based medical centers in New York City, including Rockefeller University, New York University Langone Medical Center, Memorial Sloan-Kettering Cancer Center, The Mount Sinai Medical Center, Columbia University Medical Center, Albert Einstein College of Medicine of Yeshiva University and Weill Cornell Medical College, have joined Pfizer’s New York Center for Therapeutic Innovation.
“New York City is home to a wealth of world-class biotechnology resources, including academic medical centers that have been on the leading edge of translational research—making it an ideal place to establish partnerships for our Centers for Therapeutic Innovation,” said Anthony Coyle, head of Pfizer's Global Centers for Therapeutic Innovation, in a statement.
“Pfizer’s decision to bring its Centers for Therapeutic Innovation program to New York City is the latest affirmation of the City’s excellence in biomedical research and prominence as a center for innovation,” said Mayor Michael R. Bloomberg in a press release announcing the Center.
The luncheon keynote on Thursday, April 7, will be John J. Castellani, President and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA).
John Castellani became President and Chief Executive Officer of PhRMA in August 2010. As PhRMA’s President and CEO, Mr. Castellani leads an organization that represents America’s leading pharmaceutical research and biotechnology companies, which directly employ more than 600,000 men and women nationwide working to create new medicines that help patients the world over fight disease and live longer, healthier lives. PhRMA members are among the most innovative research-based companies in the world, investing an estimated $45.8 billion in new medical research and development in 2009 alone.
In assuming his new responsibilities, Mr. Castellani has pledged that PhRMA will continue to lead efforts to find patient-centered solutions to health care challenges in America and around the globe. In particular, PhRMA will focus on helping to successfully implement – and improve – the recently enacted health care reform law and will work to build a dynamic environment in the U.S. that promotes and rewards medical innovation. This new agenda will be the focus of Mr. Castellani’s keynote address.
Before joining PhRMA, Mr. Castellani was President and Chief Executive Officer of Business Roundtable, an association of chief executive officers of leading U.S. corporations with a combined workforce of nearly 12 million employees and $6 trillion in annual revenues. Business Roundtable was cited by The Financial Times as "the most influential chief executive lobbying group in the U.S." and is at the forefront of public policy debates, advocating for a vigorous, dynamic global economy. Mr. Castellani served at the Business Roundtable from May 2001 to July 2010, where he significantly strengthened the Roundtable’s reputation in Washington, DC, nationally and internationally.
The NYBA Annual Meeting brings together hundreds of bioscience professionals from the New York, the Northeast and the world for two days of high-energy insight and information. For more information go to www.nyba.org or contact Patricia Waddington, NYBA Membership Director, at 631-444-8895.
About New York Biotechnology Association
NYBA is the leading advocate for advancing the success of the biotechnology industry in New York State and is its main representative to state policy makers, the media and communities. NYBA’s mission is to support the development and growth of New York’s biotechnology industry, and serve our members and the biotechnology community by providing a network for information exchange, shared services and collective action. NYBA’s membership comprises bioscience companies, world-class research institutions and related professional services. Under the banner of The Cures Start Here®, the Association’s goal is to amplify the success New York has had and continues to have in discovering major medical advances and growing a vibrant biotech industry.
CONTACT:
New York Biotechnology Association
Nathan Tinker, 631-444-8895
KEYWORDS: United States North America New York
INDUSTRY KEYWORDS: Stem Cells Surgery Practice Management Health AIDS Biotechnology Cardiology Clinical Trials Fitness & Nutrition Genetics Hospitals Oncology Other Health Research Veterinary Science Managed Care
MEDIA:
| Logo |